title: Dialysis facility ownership and epoetin dosing in hemodialysis patients: a view from Europe.
authors.affiliation: King's College Hospital, London, United Kingdom. Iain.macdougall@kch.nhs.uk
authors.forename: Iain C
authors.initials: IC
authors.lastname: Macdougall
mesh_terms: D000554:Ambulatory Care Facilities; D000740:Anemia / Q000188:drug therapy; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000008:administration & dosage*; D005060:Europe; D006397:Hematinics / Q000008:administration & dosage*; D006801:Humans; D010067:Ownership; D011994:Recombinant Proteins; D006435:Renal Dialysis / Q000592:standards*
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa